Advanced Glycation End Products
Mostrando 1-12 de 79 artigos, teses e dissertações.
-
1. Relationship of advanced glycation end-products in hypertension in diabetic patients: a systematic review
Resumo Diabetes mellitus e hipertensão arterial estão entre os cinco fatores de risco que elevam a mortalidade no mundo. Ambas são doenças crônicas não transmissíveis (DCNT) que têm associação fisiopatológica. Os produtos finais de glicação avançada (AGEs), produzidos pela falta de controle glicêmico nos pacientes diabéticos, interagem com se
Brazilian Journal of Nephrology. Publicado em: 2022
-
2. Rubeosis faciei diabeticorum is not associated with oxidative stress and skin autofluorescence
Abstract Background Rubeosis faciei diabeticorum is a persistent facial erythema in patients with diabetes mellitus. The actual pathogenesis has not been studied. However, it is speculated to be a cutaneous diabetic microangiopathy. Objective Examine the correlation between the severity of facial erythema and the possible causes of microvascular diabetic c
An. Bras. Dermatol.. Publicado em: 09/12/2019
-
3. Association between the RAGE (receptor for advanced glycation end-products) -374T/A gene polymorphism and diabetic retinopathy in T2DM
Summary Objective: Interaction between advanced glycation end-products (AGEs) and receptor for AGEs (RAGE) in cells could affect both extracellular and intracellular structure and function, which plays a pivotal role in diabetic microvascular complications. The results from previous epidemiological studies on the association between RAGE gene -374T/A polymo
Rev. Assoc. Med. Bras.. Publicado em: 2017-11
-
4. Serum Fluorescent Advanced Glycation End (F-AGE) products in gestational diabetes patients
ABSTRACT Objectives Advanced glycation end products (AGEs) are involved in the pathogenesis and complications of diabetes mellitus (DM). Gestational DM (GDM) is characterized by increased glycemia and oxidative stress, which are factors associated with high serum AGE concentrations. The aim of this study was to evaluate the utility of a serum fluorescence
Arch. Endocrinol. Metab.. Publicado em: 13/02/2017
-
5. Clinical Value of High Mobility Group Box 1 and the Receptor for Advanced Glycation Endproducts in Head and Neck Cancer: A Systematic Review
Abstract Introduction High mobility group box 1 is a versatile protein involved in gene transcription, extracellular signaling, and response to inflammation. Extracellularly, high mobility group box 1 binds to several receptors, notably the receptor for advanced glycation end-products. Expression of high mobility group box 1 and the receptor for advanced g
Int. Arch. Otorhinolaryngol.. Publicado em: 2016-12
-
6. sRAGE no choque séptico: um potencial biomarcador de mortalidade
Objetivo: Avaliar e compreender as implicações clínicas dos níveis plasmáticos de uma isoforma solúvel de um receptor de produtos finais de glicação avançada (do inglês receptor for advanced glycation end products - sRAGE) em diferentes fases da sepse.
Rev. bras. ter. intensiva. Publicado em: 2014-12
-
7. Advanced glycation end products (AGEs) and their receptor (RAGE) induce apoptosis of periodontal ligament fibroblasts
Diabetics have an increased prevalence of periodontitis, and diabetes is one of the causative factors of severe periodontitis. Apoptosis is thought to be involved in this pathogenic relationship. The aim of this study was to investigate apoptosis in human periodontal ligament (PDL) fibroblasts induced by advanced glycation end products (AGEs) and their recep
Braz J Med Biol Res. Publicado em: 19/09/2014
-
8. Beneficial effects of banana leaves (Musa x paradisiaca) on glucose homeostasis: multiple sites of action
The acute effect of crude extract, n-butanol and aqueous residual fractions of Musa x paradisiaca L., Musaceae, leaves on glycemia, serum insulin secretion and glycogen content in an in vivo approach was evaluated. In addition, the in vitro effect on disaccharidases activity and albumin glycation was studied. The crude extract and fractions, n-butanol and aq
Rev. bras. farmacogn.. Publicado em: 13/09/2013
-
9. Epigallocatechin-3-gallate combined with alpha lipoic acid attenuates high glucose-induced receptor for advanced glycation end products (RAGE) expression in human embryonic kidney cells
Os efeitos antioxidantes de galato de epigalocatequina (EGCG) e ácido alfa lipóico (ALA) foram demonstrados em estudos anteriores. Os efeitos renais da proteção de EGCG e ALA em pacientes com lesão renal ainda estão sob investigação. A finalidade deste estudo é investigar os efeitos anti-inflamatórios e antioxidantes de EGCG e ALA em lesão de cél
An. Acad. Bras. Ciênc.. Publicado em: 17/06/2013
-
10. Inibição do estresse do retículo endoplasmático restaura o conteúdo de ABCA-1 e o efluxo de colesterol em macrófagos tratados com albumina modificada por glicação avançada / Inhibition of endoplasmic reticulum stress restores the ABCA-1 protein level and cholesterol efflux in advanced glycated albumin-treated macrophages
Produtos de glicação avançada (AGE) prejudicam o metabolismo de lipoproteínas e o transporte reverso de colesterol, o que contribui para a aterosclerose no diabete melito (DM). Em particular, a albumina modificada por AGE (albumina-AGE) reduz a remoção de colesterol por diminuir o conteúdo do receptor ABCA-1 em macrófagos. Isto se vincula ao insulto
IBICT - Instituto Brasileiro de Informação em Ciência e Tecnologia. Publicado em: 14/08/2012
-
11. O efeito pró-apoptótico de oligômeros da amilina humana não é potencializado pela lipotoxicidade em ilhotas pancreáticas de rato em cultura / The pro-apoptotic effect of human amylin oligomers is not potentiated by lipotoxicity in rat pancreatic islets in culture
The amyloid deposit is a common histopathological feature in patients with type 2 diabetes mellitus (T2DM) and it seems to be related to the pancreatic beta cell dysfunction characteristic of this disease. A study previously developed in our laboratory found that human amylin oligomers decrease mRNA expression of the glucose-dependent insulinotropic polypept
IBICT - Instituto Brasileiro de Informação em Ciência e Tecnologia. Publicado em: 25/07/2012
-
12. Albumina modificada por glicação avançada sensibiliza macrófagos à inflamação prejudicando o transporte reverso de colesterol e a atividade anti-inflamatória da HDL / Advanced glycated albumin primes macrophages to an inflammatory response that reduces reverse cholesterol transport and impairs the HDL anti-inflammatory properties
No diabete melito, produtos de glicação avançada (AGE) reduzem o efluxo de colesterol celular o que agrava o desenvolvimento da aterosclerose. Neste estudo, investigou-se o papel da albumina modificada por glicação avançada (albumina-AGE) sobre a sensibilização de macrófagos à resposta inflamatória e o impacto da secreção de citocinas, quimocina
IBICT - Instituto Brasileiro de Informação em Ciência e Tecnologia. Publicado em: 03/07/2012